Secondary Research The market for the companies offering GLP-1 agonists is arrived at by secondary data available through paid and unpaid sources, analyzing the product portfolios of the major companies in the ecosystem, their revenue mapping, and rating the companies by their performance and quality
Tufts Now: Dariush Mozaffarian : GLP-1s have captured national attention for their ability to help people achieve significant weight reduction, but successful weight loss requires more than a prescription
Support healthy weight management with a simple-to-take oral spray taken twice daily
hello, lovely friends I reported on access issues around employer insurance last year, sharing interviews with Kristi Turner, who lost her coverage on New Year's Eve while everyone else was celebrating, and Jennifer Sansabrino, a small business owner who genuinely wanted to cover her employees but did not have a single formulary available to her with GLP-1s for weight loss
Adjusting injection time can reduce nausea and digestive discomfort for many people
The FDA requires this testing for every approved medication
